https://www.selleckchem.com/products/bda-366.html
Co-medication is common among patients with allergic rhinitis (AR), but its dimension and patterns are unknown. This is particularly relevant since AR is understood differently across European countries, as reflected by rhinitis-related search patterns in Google Trends. This study aims to assess AR co-medication and its regional patterns in Europe, using real-world data. We analysed 2015-2020MASK-air European data. We compared days under no medication, monotherapy and co-medication using the visual analogue scale (VAS) levels for overal
Aimer
Commentaire
Partagez
